Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tremfya (guselkumab) and Dupixent (dupilumab) are both injectable medications used to treat different inflammatory conditions, but they have some key differences. Tremfya is specifically approved for moderate-to-severe plaque psoriasis and active psoriatic arthritis, while Dupixent is used for a wider range of conditions, including eczema, asthma, sinus congestion with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Tremfya works by blocking the IL-23 protein to reduce inflammation, whereas Dupixent blocks multiple proteins responsible for inflammation. Tremfya is typically injected every 8 weeks after the initial doses, while Dupixent's dosing varies from weekly to monthly depending on the condition being treated. Tremfya is only available as a brand-name medication, making it potentially more expensive, whereas Dupixent also lacks a generic form. Both medications can cause injection site reactions and increase the risk of infections, but Dupixent is more likely to cause eye inflammation and has a broader range of side effects.
Tremfya (guselkumab)
Dupixent (dupilumab)
Tremfya (guselkumab)
Dupixent (dupilumab)
Summary of Tremfya vs. Dupixent
Summary for Interleukin antagonist
Prescription only
Tremfya (guselkumab) is an injection for adults with certain inflammatory conditions. It helps treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Tremfya (guselkumab) is a monoclonal antibody known as an interleukin antagonist. It calms your immune system to lower inflammation. The dosing schedule is every 1 or 2 months, depending on your condition and how far along you are in treatment. Side effects are upper respiratory infections, headache, and injection site reactions. There's also a risk of other infections and liver problems as long-term side effects.
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.